#38 - Market Update: Liquidity ≠ Solvency

Market Meditations

Neal and Chris wrap up the week by discussing the stock market and the outlook of a coronavirus antibody test. Chris explains the rally in the market is still looking past a valley of weak economic activity, describing it as flying in the fog. Neal inquires about algorithmic trading, and it's volatility, and both discuss the market previously being 40% overvalued, down to 7% overvalued and it's rocket back to roughly 35% overvalue again. Furthermore, in current events, Neal discusses the FDA pulling antibody tests, and the two dive into Moderna's pump and dump scheme and Moderna's reputation moving forward. Neal responds to the lack of defenitive answers about antibody tests in research and exclaims that there is no replacement for trial and error within the studies behind a vaccine.